Wong, William; Carlson, Josh; Thariani, Rahber; … - In: PharmacoEconomics 28 (2010) 11, pp. 1001-1013
The use of pharmacogenetic testing in clinical practice is limited thus far. A potential barrier to the widespread implementation of pharmacogenetic testing is the lack of evidence on whether testing provides good value for money. The objective of this review was to provide a systematic and...